top of page

Research Library

The largest, free collection of academic references related to restorative reproductive medicine— made possible by donations.

Recent use of oral contraceptives and the risk of multiple sclerosis.

Alonso A et al. Arch Neurol. 2005.

Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.

Jernström H et al. Eur J Cancer. 2005.

Risk factors for inflammatory bowel disease in the general population.

García Rodríguez LA et al. Aliment Pharmacol Ther. 2005.

Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Prior JC. Endocrine. 2005.

Determination of the fertile window: reproductive competence of women--European cycle databases.

Frank-Herrmann P et al. Gynecol Endocrinol. 2005.

Ultrastructure of the human periovulatory cervical mucus.

Ceric F et al. J Electron Microsc (Tokyo). 2005.

An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate-resistant polycystic ovarian syndrome.

Farquhar CM. Curr Opin Obstet Gynecol. 2005.

A new method for estimating the effectiveness of emergency contraception that accounts for variation in timing of ovulation and previous cycle length.

Mikolajczyk RT et al. Fertil Steril. 2005.

Over-the-counter progesterone cream produces significant drug exposure compared to a food and drug administration-approved oral progesterone product.

Hermann AC et al. J Clin Pharmacol. 2005.

Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations.

Milne RL et al. Cancer Epidemiol Biomarkers Prev. 2005.

Adolescent pregnancy prevention: An abstinence-centered randomized controlled intervention in a Chilean public high school.

Cabezón C et al. J Adolesc Health. 2005.

Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization.

Roberts JE et al. Fertil Steril. 2005.

New low- and high-tech calendar methods of family planning.

Fehring RJ. J Midwifery Womens Health. 2005.

Use of contraception and use of family planning services in the United States: 1982-2002.

Mosher WD et al. Adv Data. 2005.

Evidence about extending the duration of oral contraceptive use to suppress menstruation.

Hitchcock CL et al. Womens Health Issues. 2004.

Endometriosis.

Giudice LC et al. Lancet. 2004.

Vitamin D2 is much less effective than vitamin D3 in humans.

Armas LA et al. J Clin Endocrinol Metab. 2004.

Fertility awareness-based methods for contraception.

Grimes DA et al. Cochrane Database Syst Rev. 2004.

Efficacy of the new TwoDay Method of family planning.

Jennings V et al. Fertil Steril. 2004.

The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle.

Miro F et al. Hum Reprod. 2004.

Selenium in pregnancy: is selenium an active defective ion against environmental chemical stress?

Kantola M et al. Environ Res. 2004.

Proactive management of menstrual cycle abnormalities in young women.

Barron ML. J Perinat Neonatal Nurs. 2004.

A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia.

Lenzi A et al. Fertil Steril. 2004.

Safety concerns and health benefits associated with oral contraception.

Burkman R et al. Am J Obstet Gynecol. 2004.

Aromatase inhibitors in ovulation induction.

Mitwally MF et al. Semin Reprod Med. 2004.

  • Page 35
bottom of page